Has Diane Schmidt, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,267 in general payments to Diane Schmidt, MD across 18 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Diane Schmidt, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Diane Schmidt, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Diane Schmidt, MD

Endocrinology, Diabetes & Metabolism · Quakertown, PANPI 1124028212

Payments from drug & device makers

$1,267in general payments, 2019–2025

Across 18 payments — averaging $70.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Dexcom, Inc.$324
Medtronic$313
BETA Bionics, Inc.$155
Tandem Diabetes Care, Inc.$145
Amgen$125
Sequel Med Tech, LLC$124
plus $81 from 2 others

What the payments were for

Food & beverage$1,267100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Dexcom, Inc.	5	$324
Medtronic	3	$313
BETA Bionics, Inc.	2	$155
Tandem Diabetes Care, Inc.	3	$145
Amgen	1	$125
Sequel Med Tech, LLC	1	$124
Radius Health, Inc.	1	$50
Abbott	2	$32

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

iLet Bionic Pancreas$329
MINIMED 780G$247
DEXCOM G6 TRANSMITTER$241
EVENITY$125
TWIIST$124
t:slim X2 Insulin Pump with Control-IQ$111
iLet Insulin Infusion Kit Inset$110
iLet Insulin Infusion Kit Contact Detach$110

How this compares

$1,267 in reported general payments places this provider in the 50th percentile of 388 endocrinology, diabetes & metabolism providers in Pennsylvania.

See all endocrinology, diabetes & metabolism providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$428,823

Medicare patients

1,058

Services billed

9,309

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OzempicSemaglutide	149	$215,286
JardianceEmpagliflozin	143	$130,204
JanuviaSitagliptin Phosphate	119	$125,575
FarxigaDapagliflozin Propanediol	81	$66,285
Tresiba Flextouch U-100Insulin Degludec	78	$48,239
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog	55	$46,449
TrulicityDulaglutide	31	$44,574
SynthroidLevothyroxine Sodium	425	$38,365
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog	19	$34,017
Humalog Kwikpen U-100Insulin Lispro	65	$30,211
Novolog FlexpenInsulin Aspart	114	$29,307
Humalog Kwikpen U-200Insulin Lispro	14	$24,297
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	154	$24,245
MounjaroTirzepatide	18	$23,970
InvokanaCanagliflozin	20	$22,957

Paid to pharmacies, not to this prescriber.

Other endocrinology, diabetes & metabolism in Quakertown

Mona Al MukaddamPhiladelphia$3.9M
Serge JabbourPhiladelphia$3.1M
Mihaela BiscoveanuPhiladelphia$1.5M
Barbara SimonPhiladelphia$1M
Mitchell LazarPhiladelphia$1M
Vijay BahlPittsburgh$998K
Intekhab AhmedPhiladelphia$926K
Erin KershawPittsburgh$804K
Geraldo SaavedraWhitehall$698K
Arvind CavaleFeasterville Trevose$662K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →